1Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardi- ovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32 ( Suppll ) : S112 - S119.
2United States Renal Data System. USRDS 1999 Annual Data Re- port. Bethesda, Md : National Institutes of Health, National In- stitute of Diabetes and Digestive and Kidney Disease; 1999. A- vailable at www. usrds, org/chapters/ch06, pdf. Accessed De- cember 10, 2002.
3Qunibi WY, Nolan CA, Ayus JC. Cardiovascular calcification in patients with end -stage renal disease: A century old phenome- non. Kidney Int,2002,62( Suppl 82) :$73 -$80.
4London GM, Gu6rin AP, Marchais SJ, et al. Arterial media calci- fication in end - stage renal disease: impact on all - cause and cardiovascular mortality. Nephrol Dial Transplant, 2003,18 ( 9 ) : 1731 - 1740.
5Verberckmoes SC, Persy V, Behets GJ, et al. Uremia - related vascular calcification: more than apatite deposition. Kidney Int, 2007,71 ( 1 ) :298 -303.
6Goodman WG,London G,Amann K,et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis,2004,43(2):572-579.
7Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from calcific uremic artriolopathy. Am J Kidney Dis, 1998,32 (2) :384 -391.
8Noordzij M, Korevaa JC, Boeschoten EW, et al. The Kidney Dis- ease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in di- alysis patients. Am J Kidney Dis ,2005,46(5 ) :925 - 932.
